10x Genomics, Inc. — Director's Dealing 2021

Nov 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-11-22

Reporting Person: Saxonov Serge (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-22	Class A Common Stock	S	772	$148.3811	Disposed	884609	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	4498	Indirect
Class A Common Stock	89960	Indirect

Footnotes

F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2: The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

F3: The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.